(AD) Koninklijke Ahold Delhaize - Ratings and Ratios
Groceries, Pharmacy, Liquor, Gasoline, E-Commerce
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.52% |
| Yield on Cost 5y | 5.66% |
| Yield CAGR 5y | 9.19% |
| Payout Consistency | 79.3% |
| Payout Ratio | 44.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 16.3% |
| Value at Risk 5%th | 26.0% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | 1.14 |
| CAGR/Max DD | 0.60 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.525 |
| Beta | -0.057 |
| Beta Downside | -0.175 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.67% |
| Mean DD | 5.77% |
| Median DD | 4.87% |
Description: AD Koninklijke Ahold Delhaize December 17, 2025
Koninklijke Ahold Delhaize N.V. (ticker AD) is a multinational food-retail operator headquartered in Zaandam, the Netherlands. It runs supermarkets, convenience stores and e-commerce sites across the Netherlands, the United States and several international markets under brands such as Albert, Delhaize, Food Lion, Giant, Stop & Shop, and Super Indo, offering a full assortment from fresh produce to pharmacy items and gasoline.
In FY 2023 the company reported a 4 % same-store sales increase in its U.S. segment and a 10 % year-over-year rise in online grocery revenue, reflecting the broader industry shift toward omnichannel shopping. Operating margins hovered around 4.5 %, while private-label sales now represent roughly 30 % of total revenue-a key lever for margin expansion. Core economic drivers include inflation-linked price sensitivity in discretionary categories (beer, wine, tobacco) and rising labor costs, which together constrain earnings growth unless offset by efficiency gains and price-elasticity management.
For a deeper dive into AD’s valuation nuances, the ValueRay platform offers a data-rich toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.07b TTM) > 0 and > 6% of Revenue (6% = 5.53b TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5.57% (prev -3.63%; Δ -1.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 6.61b > Net Income 2.07b (YES >=105%, WARN >=100%) |
| Net Debt (805.0m) to EBITDA (5.70b) ratio: 0.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (896.9m) change vs 12m ago -2.64% (target <= -2.0% for YES) |
| Gross Margin 26.45% (prev 26.88%; Δ -0.43pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 190.7% (prev 187.1%; Δ 3.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.49 (EBITDA TTM 5.70b / Interest Expense TTM 808.0m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 69.44
| 1. Piotroski 5.50pt |
| 2. FCF Yield 14.15% |
| 3. FCF Margin 5.17% |
| 4. Debt/Equity 0.54 |
| 5. Debt/Ebitda 0.14 |
| 6. ROIC - WACC (= 2.65)% |
| 7. RoE 14.04% |
| 8. Rev. Trend 67.26% |
| 9. EPS Trend -34.30% |
What is the price of AD shares?
Over the past week, the price has changed by -1.95%, over one month by -3.08%, over three months by -6.58% and over the past year by +7.81%.
Is AD a buy, sell or hold?
What are the forecasts/targets for the AD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.7 | 12.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36 | 7.1% |
AD Fundamental Data Overview January 12, 2026
P/E Trailing = 14.8018
P/E Forward = 12.2249
P/S = 0.325
P/B = 2.1601
P/EG = 1.8346
Beta = 0.3
Revenue TTM = 92.14b EUR
EBIT TTM = 2.01b EUR
EBITDA TTM = 5.70b EUR
Long Term Debt = 4.59b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.89b EUR (from shortLongTermDebt, last fiscal year)
Debt = 7.48b EUR (Calculated: Short Term 2.89b + Long Term 4.59b)
Net Debt = 805.0m EUR (from netDebt column, last quarter)
Enterprise Value = 33.64b EUR (29.94b + Debt 7.48b - CCE 3.79b)
Interest Coverage Ratio = 2.49 (Ebit TTM 2.01b / Interest Expense TTM 808.0m)
EV/FCF = 7.07x (Enterprise Value 33.64b / FCF TTM 4.76b)
FCF Yield = 14.15% (FCF TTM 4.76b / Enterprise Value 33.64b)
FCF Margin = 5.17% (FCF TTM 4.76b / Revenue TTM 92.14b)
Net Margin = 2.24% (Net Income TTM 2.07b / Revenue TTM 92.14b)
Gross Margin = 26.45% ((Revenue TTM 92.14b - Cost of Revenue TTM 67.77b) / Revenue TTM)
Gross Margin QoQ = 26.46% (prev 26.45%)
Tobins Q-Ratio = 0.69 (Enterprise Value 33.64b / Total Assets 49.03b)
Interest Expense / Debt = 2.75% (Interest Expense 206.0m / Debt 7.48b)
Taxrate = 23.40% (175.0m / 748.0m)
NOPAT = 1.54b (EBIT 2.01b * (1 - 23.40%))
Current Ratio = 0.70 (Total Current Assets 12.14b / Total Current Liabilities 17.27b)
Debt / Equity = 0.54 (Debt 7.48b / totalStockholderEquity, last quarter 13.86b)
Debt / EBITDA = 0.14 (Net Debt 805.0m / EBITDA 5.70b)
Debt / FCF = 0.17 (Net Debt 805.0m / FCF TTM 4.76b)
Total Stockholder Equity = 14.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.28% (Net Income 2.07b / Total Assets 49.03b)
RoE = 14.04% (Net Income TTM 2.07b / Total Stockholder Equity 14.71b)
RoCE = 10.43% (EBIT 2.01b / Capital Employed (Equity 14.71b + L.T.Debt 4.59b))
RoIC = 7.64% (NOPAT 1.54b / Invested Capital 20.20b)
WACC = 4.99% (E(29.94b)/V(37.42b) * Re(5.71%) + D(7.48b)/V(37.42b) * Rd(2.75%) * (1-Tc(0.23)))
Discount Rate = 5.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.02%
[DCF Debug] Terminal Value 87.29% ; FCFF base≈4.54b ; Y1≈5.03b ; Y5≈6.54b
Fair Price DCF = 215.5 (EV 192.87b - Net Debt 805.0m = Equity 192.07b / Shares 891.2m; r=5.90% [WACC]; 5y FCF grow 12.41% → 2.90% )
EPS Correlation: -34.30 | EPS CAGR: -45.70% | SUE: -4.0 | # QB: 0
Revenue Correlation: 67.26 | Revenue CAGR: 2.98% | SUE: -0.09 | # QB: 0
EPS next Year (2026-12-31): EPS=2.75 | Chg30d=+0.027 | Revisions Net=-3 | Growth EPS=+4.7% | Growth Revenue=+1.8%